State of Science Summit- Breast Cancer: Chaired by Anna Weiss, MD

Article

In Partnership With:

State of Science Summit- Breast Cancer: Chaired by Anna Weiss, MD

State of Science Summit- Breast Cancer: Chaired by Anna Weiss, MD

Speakers

  • Ajay Dhakal, MBBS | UR Medicine’s Wilmot Cancer Institute
  • Carla Falkson, MD, MBChB, MMed | UR Medicine’s Wilmot Cancer Institute
  • Kimberly Gergelis, MD | UR Medicine’s Wilmot Cancer Institute
  • Jessica Gooch, MD | UR Medicine’s Wilmot Cancer Institute
  • Alissa Huston Porter, MD | UR Medicine’s Wilmot Cancer Institute
  • Cansu Karakas, MD | UR Medicine’s Wilmot Cancer Institute
  • Marilyn Ling, MD | UR Medicine’s Wilmot Cancer Institute
  • Ruth O’Regan, MD | UR Medicine’s Wilmot Cancer Institute

Topics

  • Management of TNBC
  • Role of CDK 4/6 for the Treatment of HER2-/ HR+ Breast Cancer
  • Case-Based Discussion: CDK4/6 inhibitors
  • Managing HER2+ Breast Cancer with ADCs and Monoclonal Antibodies
  • Case-Based Discussion: HER2Low
  • Local Regional Management after NAC – Axillary Surgery
  • Local Regional Management – Multi-Disciplinary Considerations for Radiation
  • Case-Based Discussion – Axillary Management

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Manmeet Singh Ahluwalia, MD
Rita Nanda, MD
Video 5 - "AE Management with CDK4/6 Inhibitors: Strategies for Treatment Continuity and Optimal Patient Outcomes"
Rita Nanda, MD
Siddartha Yadav, MD, FACP
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Ko Un “Clara” Park, MD
Erin Frances Cobain, MD